Cargando…
Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration
Unpredictable outbreaks due to respiratory viral infections emphasize the need for new drug delivery strategies to the entire respiratory tract. As viral attack is not limited to a specific anatomic region, antiviral therapy that targets both the upper and lower respiratory tract would be most effec...
Autores principales: | Seow, Han Cong, Liao, Qiuying, Lau, Andy T.Y., Leung, Susan W.S., Yuan, Shuofeng, Lam, Jenny K.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958263/ https://www.ncbi.nlm.nih.gov/pubmed/35358643 http://dx.doi.org/10.1016/j.ijpharm.2022.121704 |
Ejemplares similares
-
Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
por: Seow, Han Cong, et al.
Publicado: (2023) -
Nasal Powder Formulations: In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
por: Trenkel, Marie, et al.
Publicado: (2021) -
Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze Travel®)
por: Hiltunen, Raimo, et al.
Publicado: (2007) -
A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies
por: Nižić Nodilo, Laura, et al.
Publicado: (2021) -
Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder
por: Ball, Jordan P., et al.
Publicado: (2017)